Trial Profile
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2010
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 20 Jan 2010 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
- 20 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2009 Planned end date changed from 1 Sep 2008 to 1 May 2009 as reported by ClinicalTrials.gov.